InVitro International, Inc. (IVRO)

OTCMKTS · Delayed Price · Currency is USD

0.1500

0.00 (0.00%)

At close: Jan 23, 2026

Revenue by Product

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2013 - 2019
In-vitro (Non-animal) Consumer, Product, and Environmental Safety Test Method	811.29K	Log In	Log In	Log In	Log In	Upgrade
In-vitro (Non-animal) Consumer, Product, and Environmental Safety Test Method Growth	2.35%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2013 - 2019
United States	513.22K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-0.76%	Log In	Log In	Log In	Log In	Upgrade
Other Countries	298.07K	Log In	Log In	Log In	Log In	Upgrade
Other Countries Growth	8.20%	Log In	Log In	Log In	Log In	Upgrade